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Background
Rotavirus vaccination (RV) is recognized by international
health authority as the best strategy to prevent rotavirus
gastroenteritis (RVGE) in children. Costs of RVGE were
estimated in several studies and were classified into direct and
indirect costs, that should be further divided into Health care
and social perspective. This study aims to evaluate RVGE
hospitalization costs in Sicily, before and after universal mass
RV (UMRV) introduction.
Methods
Cases of RVGE were defined as all hospitalizations with an
ICD-9-CM diagnosis code of 008.61 on any diagnosis position
among children aged 0 to 59 months. Data were obtained from
Hospital discharge records (HDR) of the Health Regional
Office from 2009 to 2014. Direct and indirect costs of RVGE
hospitalization for health care and social perspective were
calculated on data reported in the REVEAL study. RV costs
was extrapolated from a budget impact analysis published in
2013 by Vitale et al.
Results
In Sicily, during the pre-vaccination era (2009-2012) were
reported 963 RVGE hospitalizations per year with a mean
HDR cost of 1,521E (1,465,000E per year) , against 511 RVGE
cases per year (mean HDR cost of 1,321E; 675,000E per year)
after UMRV introduction (direct hospitalization Health care
costs). Moreover, direct and indirect hospitalization costs for
social perspective was estimated 1.5 times bigger than direct
hospitalization health care cost (pre-vaccination era
2,255,000E per year, post-vaccination era 1,020,000E per
year). Finally, cost of RV vaccine in Sicily in 2013 and 2014 was
1,300,000E per year (mean vaccination coverage 37%). In
Sicily after RV introduction, every year was estimated a 46%
reduction of RVGE hospitalizations and a 700,000E benefit for
Regional fund.
Conclusions
Despite low vaccination rate and even though the inability to
evaluate the impact of RV vaccination on primary care and
emergency access for RVGE, our study demonstrated the high
cost-effectiveness of UMRV on hospitalization rate and costs
in Sicily.
Key messages
 In Sicily after UMRV introduction was observed a 46%
reduction per year of RVGE hospitalizations respect to pre-
vaccination era
 Moreover, was reported a 700,000E yearly decrease of
RVGE direct and indirect hospitalization costs according to
health care and social perspective
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